Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeoCore Technology CoROCO:4131 -0.92%55 Days Payable is 36.08 as of Sep. 2025, which is 78% below its 10-year median of 164.41. GuruFocus rates ROCO:4131 with a GF Score™ of 55/100 and a GF Value™ of NT$37.64 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 701 Biotechnology companies, NeoCore Technology Co ranks worse than 72.18% on this metric.
NeoCore Technology Co Days Payable Historical Data
* Premium members only.
The historical data trend for NeoCore Technology Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4131 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, NeoCore Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeoCore Technology Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NeoCore Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where NeoCore Technology Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NeoCore Technology Co's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeoCore Technology Co (ROCO:4131) has a Days Payable of 36.08 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NeoCore Technology Co and its competitors. This is 78% below median its historical median of 164.41. Over the past decade, NeoCore Technology Co's Days Payable has ranged from 4.97 to 300.09. According to the industry distribution chart, NeoCore Technology Co ranks #506 out of 701 companies in the Biotechnology industry, placing it in the top 72.2%.
Is NeoCore Technology Co's Days Payable too high?
NeoCore Technology Co's current Days Payable of 36.08 is 78% below median its 10-year median of 164.41. Over the past 10 years, this metric has ranged from a low of 4.97 to a high of 300.09. The Biotechnology industry median Days Payable is 112.84. NeoCore Technology Co's value of 36.08 is 68% below this industry median. Based on the distribution chart, NeoCore Technology Co ranks #506 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, NeoCore Technology Co has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NeoCore Technology Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NeoCore Technology Co ranks #506 out of 701 companies for Days Payable. This places NeoCore Technology Co in the lower half of its industry. The industry median Days Payable is 112.84. NeoCore Technology Co's value of 36.08 is 68% below this benchmark. Historically, NeoCore Technology Co's own Days Payable has ranged from 4.97 to 300.09 over the past decade. While the company's 10-year median is 164.41 vs. the industry median of 112.84, NeoCore Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeoCore Technology Co's current Days Payable of 36.08 is 68% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NeoCore Technology Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeoCore Technology Co's current Days Payable is 36.08, which is 78% below median its own 10-year median of 164.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeoCore Technology Co stock overvalued right now?
Based on GuruFocus' analysis, NeoCore Technology Co (ROCO:4131) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$37.64, compared to a current price of NT$32.20 — trading 14.5% below its estimated fair value. The current Days Payable is 36.08, which is 78% below median its 10-year median of 164.41 and 68% below the Biotechnology industry median of 112.84. NeoCore Technology Co's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NeoCore Technology Co (ROCO:4131), the current Days Payable is 36.08 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeoCore Technology Co (ROCO:4131) Overvalued in 2026?
Based on GuruFocus' analysis, NeoCore Technology Co stock appears to be undervalued.
The current stock price of NT$32.20 is trading 14.5% below its estimated GF Value™ of NT$37.64.
GuruFocus considers NeoCore Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:4131:
Days Payable: 36.08 (78% below median its 10-year median of 164.41)
GF Value™: NT$37.64 vs. price of NT$32.20 (14.5% below fair value)
Industry Position: 68% below the Biotechnology median (#506 of 701)
No single metric tells the full story. See the ROCO:4131 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeoCore Technology Co Ltd develops integrated bio-chip technology. Its products are used for food, beer, agriculture, livestock, and human disease testing.
55GF Score
Get the complete analysis for ROCO:4131
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4131 has been successfully added to your 
